Page last updated: 2024-09-03

op 2507 and 6-ketoprostaglandin f1 alpha

op 2507 has been researched along with 6-ketoprostaglandin f1 alpha in 5 studies

Compound Research Comparison

Studies
(op 2507)
Trials
(op 2507)
Recent Studies (post-2010)
(op 2507)
Studies
(6-ketoprostaglandin f1 alpha)
Trials
(6-ketoprostaglandin f1 alpha)
Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha)
33014,832294150

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwata, M1
Ishii, T; Kai, T; Kamada, N; Kim, YI; Kitano, S; Sugimachi, K; Tatsuma, T1
Iida, T; Kawarada, Y; Yokoi, H1
Arima, T; Hirano, T; Kawano, R; Motoyama, K; Nakafusa, Y; Sugitani, A; Tanaka, M1
Kawamoto, T; Kurata, M; Ohkohchi, N; Okajima, K; Uchiba, M1

Other Studies

5 other study(ies) available for op 2507 and 6-ketoprostaglandin f1 alpha

ArticleYear
Pathophysiology of dogs after 84% hepatectomy with emphasis on prostaglandin metabolites and the effect of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analog.
    Surgery today, 1994, Volume: 24, Issue:12

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cause of Death; Dogs; Epoprostenol; Female; Hepatectomy; Histamine Antagonists; Hyaluronic Acid; Liver; Liver Function Tests; Male; Methacrylates; Prostaglandins; Radioimmunoassay; Survival Rate; Thromboxane B2; Thromboxane-A Synthase; Time Factors

1994
Hepatoprotection by a PGI2 analogue in complete warm ischemia of the pig liver. Prostanoid release from the reperfused liver.
    Transplantation, 1994, Oct-27, Volume: 58, Issue:8

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspartate Aminotransferases; Cryoprotective Agents; Dinoprostone; Endotoxins; Epoprostenol; Female; Ischemia; Liver; Prostaglandins; Swine; Thromboxane B2

1994
The effects of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analogue on experimental acute necrotizing pancreatitis in rats.
    Pancreas, 1998, Volume: 17, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Disease Models, Animal; Epoprostenol; Injections, Subcutaneous; Kidney; Lung; Male; Methacrylates; Pancreas; Pancreatitis, Acute Necrotizing; Phospholipases A; Phospholipases A2; Rats; Rats, Wistar; Survival Rate; Taurocholic Acid; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Time Factors

1998
The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
    Surgery, 2001, Volume: 129, Issue:5

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Arteriosclerosis; Cell Nucleus; Drug Therapy, Combination; Enzyme Inhibitors; Epoprostenol; Kinetics; Male; Methacrylates; Rats; Rats, Inbred Lew; Rats, Wistar; Superoxides; Thromboxane A2; Thromboxane-A Synthase; Transplantation, Homologous

2001
Antithrombin reduces reperfusion-induced hepatic metastasis of colon cancer cells.
    World journal of gastroenterology, 2006, Jan-07, Volume: 12, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antithrombins; Arginine; Cell Line, Tumor; Colonic Neoplasms; E-Selectin; Epoprostenol; Fibrin Fibrinogen Degradation Products; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Pipecolic Acids; Rats; Rats, Inbred F344; Reperfusion; RNA, Messenger; Sulfonamides; Tumor Necrosis Factor-alpha

2006